We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$37.8B
AUM Growth
+$3.94B
Cap. Flow
+$1.54B
Cap. Flow %
4.08%
Top 10 Hldgs %
22%
Holding
1,437
New
65
Increased
570
Reduced
395
Closed
99

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$73.7M
2
LIN icon
Linde
LIN
+$68.9M
3
SHW icon
Sherwin-Williams
SHW
+$52.4M
4
MDT icon
Medtronic
MDT
+$52.2M
5
CRM icon
Salesforce
CRM
+$51.8M

Sector Composition

Rank Sector Weight
1 Technology 23.8%
2 Healthcare 19.83%
3 Financials 11.79%
4 Industrials 9.64%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVAX icon
1201
Novavax
NVAX
$1.29B
$230K ﹤0.01%
23,900
-1,950
-8% -$34.4K
AIV
1202
Aimco
AIV
$382M
$229K ﹤0.01%
32,190
AXON
1203
Axon Enterprise
AXON
$51B
$228K ﹤0.01%
1,395
-733
-34% -$116K
SGMO
1204
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$226K ﹤0.01%
76,900
BDN
1205
Brandywine Realty Trust
BDN
$539M
$224K ﹤0.01%
36,425
RPTX
1206
DELISTED
Repare Therapeutics
RPTX
$221K ﹤0.01%
14,600
ITOS
1207
DELISTED
iTeos Therapeutics
ITOS
$220K ﹤0.01%
11,300
NVEI
1208
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$220K ﹤0.01%
8,643
+149
+2% +$4.22K
MRCY icon
1209
Mercury Systems
MRCY
$6.49B
$219K ﹤0.01%
5,061
+1,516
+43% +$71.7K
FSLY icon
1210
Fastly Inc
FSLY
$4.59B
$217K ﹤0.01%
27,000
DSGX icon
1211
Descartes Systems
DSGX
$6.83B
$215K ﹤0.01%
+3,076
New +$210K
CIO
1212
DELISTED
City Office REIT
CIO
$209K ﹤0.01%
24,654
DTM icon
1213
DT Midstream
DTM
$13.9B
$209K ﹤0.01%
3,782
CRNX icon
1214
Crinetics Pharmaceuticals
CRNX
$8.94B
$206K ﹤0.01%
11,300
WMK icon
1215
Weis Markets
WMK
$1.77B
$206K ﹤0.01%
2,457
-352
-13% -$29.7K
MXCT icon
1216
MaxCyte
MXCT
$134M
$205K ﹤0.01%
38,500
ESRT icon
1217
Empire State Realty Trust
ESRT
$822M
$204K ﹤0.01%
30,106
IDYA icon
1218
IDEAYA Biosciences
IDYA
$3.57B
$203K ﹤0.01%
11,300
EDIT icon
1219
Editas Medicine
EDIT
$452M
$202K ﹤0.01%
22,400
NXRT
1220
NexPoint Residential Trust
NXRT
$644M
$201K ﹤0.01%
4,593
COOP
1221
DELISTED
Mr. Cooper
COOP
$198K ﹤0.01%
5,000
ASTL icon
1222
Algoma Steel
ASTL
$472M
$192K ﹤0.01%
30,741
+11,338
+58% +$74.4K
NWS icon
1223
News Corp Class B
NWS
$17.6B
$191K ﹤0.01%
10,445
+10,040
+2,479% +$177K
OSPN icon
1224
OneSpan
OSPN
$601M
$191K ﹤0.01%
17,200
TOST icon
1225
Toast
TOST
$20.3B
$191K ﹤0.01%
+10,704
New +$201K

Similar funds

DekaBank Deutsche Girozentrale's Q4 2022 Portfolio in Review

As of Q4 2022, DekaBank Deutsche Girozentrale held 1,437 positions worth $37.8B, up 12% from $33.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

DekaBank Deutsche Girozentrale deployed $1.54B of net new capital in Q4 2022, opening 65 new positions and adding to 570 existing holdings. Its largest new stake was Wolfspeed: 120,839 shares worth $8.28M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $73.7M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q4 2022 buy was Wolfspeed: 120,839 shares worth $8.28M.
  • DekaBank Deutsche Girozentrale added most to Alphabet (Google) Class A in Q4 2022, an estimated $186M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $73.7M.
  • DekaBank Deutsche Girozentrale fully exited Duke Realty Corp. in Q4 2022, selling an estimated $16.3M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 22% of its $37.8B portfolio in Q4 2022.
  • DekaBank Deutsche Girozentrale opened 65 new positions and closed 99 in Q4 2022.
  • DekaBank Deutsche Girozentrale's portfolio value rose 12% quarter-over-quarter to $37.8B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2022, filed 1 Feb 2023.